Deutsche Märkte schließen in 8 Stunden 4 Minuten

Quotient Limited (QTNT)

NasdaqGM - NasdaqGM Echtzeitpreis. Währung in USD
Zur Watchlist hinzufügen
2,1000+0,0500 (+2,44%)
Börsenschluss: 04:00PM EST
1,9900 -0,11 (-5,24%)
Nachbörse: 04:03PM EST

Quotient Limited

B1, Business Park Terre Bonne
Route de Crassier 13
Eysins 1262
Switzerland
11 41 22 716 9800
https://www.quotientbd.com

Sektor(en)Healthcare
BrancheDiagnostics & Research
Vollzeitmitarbeiter433

Leitende Angestellte

NameTitelZahlenAusgeübtGeburtsjahr
Mr. Peter BuhlerExec. Officer761,15kN/A1970
Mr. Manuel O. MendezCEO & DirectorN/AN/A1968
Mr. Ali KiboroChief Financial OfficerN/AN/AN/A
Ms. Vittoria BonassoHead of Fin., Group Controller & Principal Accounting OfficerN/AN/A1976
Dr. Michael HausmannChief Technology OfficerN/AN/AN/A
Dr. Christine GinocchioChief Scientific & Medical OfficerN/AN/AN/A
Mr. Christian AlbrichChief People OfficerN/AN/A1964
Mr. Mohammad El KhouryChief Commercial OfficerN/AN/AN/A
Die Beträge haben den Stand 31. Dezember 2021 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, commercializes, and sells products for the global transfusion diagnostics market in the United States, France, Japan, and internationally. The company is developing MosaiQ, a proprietary technology platform, which provides tests for immunohematology, serological disease screening, and molecular disease screening. Its conventional reagent products for blood grouping include antisera products that are used to identify blood group antigens; reagent red blood cells, which enable the identification of blood group antibodies; whole blood control products for use as daily quality assurance tests; and ancillary products that are used to support blood grouping. The company also offers MosaiQ COVID-19 Microarray that is designed as a serological disease screening microarray specific to COVID-19 antibody detection. It sells its products to hospitals, donor collection agencies, independent testing laboratories, original equipment manufacturers, and blood banking operation and other diagnostics companies. Quotient Limited was founded in 2007 and is headquartered in Eysins, Switzerland.

Corporate Governance

Quotient Limiteds ISS Governance QualityScore, Stand 26. September 2021, lautet 5. Die grundlegenden Scores sind Audit: 10, Vorstand: 3, Shareholderrechte: 3, Kompensation: 8.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.